Comparison of the structures of the cyclotheonamide A complexes of human α-thrombin and bovine β-trypsin

Protein Science

Volumn 5, Issue 5, 1996, Pages 825-835

  Ganesh, V ^a   Lee, A Y ^b   Clardy, J ^b   Tulinsky, A ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Department of Molecular Biology and Genetics   (United States)

Author keywords

cyclotheonamide A; thrombin; transition state analogue; trypsin; keto amide

Indexed keywords

CYCLOTHEONAMIDE A; PENTAPEPTIDE; THROMBIN; TRYPSIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CATTLE; COMPARATIVE STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME INHIBITION; HEMOSTASIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; THROMBOSIS;

EID: 0029985841     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560050504     Document Type: Article

References (53)

1. Albers MW, Walsh CT, Schreiber SL. 1990. Substrate specificity for the human rotamase FKBP: A view of FK506 and rapamycin as leucine-(twisted amide)-proline mimics. J Org Chem 55:4984-4986.
2. Bajusz S, Szell E, Bagdy D, Barabas E, Horvath G, Dioszegi M, Fittler Z, Szabo G, Juhasz A, Tomori E, Szilagyi G. 1990. Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-Me-Phe-Pro-Arg-H. J Mol Chem 33:1729-1735.
3. Bar-Shavit R, Kahn A, Mudd MS, Wilner GD, Mann KG, Fenton JW II. 1984. Localization of a chemotactic domain in human thrombin. Biochemistry 23:397-400.
4. Bartunik HD, Summers LJ, Bartsch HH. 1989. Crystal structure of bovine β-trypsin at 1.5 Å resolution in a crystal form with low molecular packing density. J Mol Biol 210:813-828.
5. Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. 1989. The refined 1.9 Å crystal structure of human α-thrombin: Interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J 8:3467-3475.
6. α2-naphthyl-sulphonyl-giycyl)-DL-p-arnidinophenylalanyl- piperidine (NAPAP) and (2R,4R)-4-methyl-1-[N-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulphonyl)-L- arginyl]-2-piperidine carboxylic acid (MQPA) to human α-thrombin. Eur J Biochem 93:175-182.
7. Bode W, Turk D, Karshikov A. 1992. The refined 1.9-Å X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human α-thrombin: Structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci 1:426-471.
8. Brunger AT. 1990. Extension of molecular replacement: A new search strategy based on Patterson correlation refinement. Acta Crystallogr A 46:46.
9. Brünger AT. 1992. X-PLOR manual, version 3.1. New Haven, Connecticut: Yale University Press.
10. Brunger AT, Krukowski A, Erickson J. 1990. Slow-cooling protocols for crystallographic refinement. Acta Crystallogr A 46:585-593.
11. DiMaio J, Gibbs B, Munn D, Lefebre J, Ni F, Konishi Y. 1990. Bifunctional thrombin inhibitors based on the sequence of hirudin. J Biol Chem 265: 21698-21703.
12. Fenton JW II. 1988a. Regulation of thrombin generation and functions. Semin Thromb Hemost 14:234-240.
13. Fenton JW II. 1988b. Thrombin bioregulatory functions. Adv Clin Enzymol 6:186-193.
14. Finzel BC. 1987. Incorporation of fast Fourier transforms to speed restrained least-squares refinement of protein structures. J Appl Crystallogr 20: 53-55.
15. Fusetani N, Matsunaga S, Matsumoto H, Takebayashi Y. 1990. Cyclotheonamides, potent thrombin inhibitors, from a marine sponge Theonella sp. J Am Chem Soc 112:7053-7054.
16. Glover G, Shaw E. 1971. Purification of thrombin and isolation of a peptide containing the active center histidine. J Biol Chem 246:4594-4601.
17. Haghihara M, Schreiber SL. 1992. Reassignment of stereochemistry and total synthesis of the thrombin inhibitor cyclotheonamide B. J Am Chem Soc 114:6570-6571.
18. Hakansson K, Tulinsky A, Abelman MA, Miller TA, Vlasuk GP, Bergum PN, Lim-Wilby MSL, Brunck TK. 1995. Crystallographic Structure of a peptidyl keto acid inhibitor and human α-thrombin. Bioorg & Med Chem 3:1009-1017.
19. Hendrickson WA, Konnert JH. 1980. Stereochemically restrained crystallographic least-squares refinement of macromolecular structures. In: Srinivasan R, ed. Biomolecular structure, function, conformation and evolution. Oxford: Pergamon Press, pp 43-57.
20. Higashi T. 1990. Auto-indexing of oscillation images. J Appl Crystallogr 23:253-257.
21. Howard AD, Nielson C, Xuong NH. 1985. Software for a diffractometer with multiwire area detector. Methods Enzymol 114:452-472.
22. Hu LY, Abeles RH. 1990. Inhibition of cathepsin B and papain by peptidyl α-keto esters, α-ketoamides, α-diketones and α-ketoacids. Arch Biochem Biophys 281:271-274.
23. Huber R, Bode W. 1978. Structural basis of the activation and activation of trypsin. Acc Chem Res 11:114-122.
24. Huff JR. 1991. HIV protease: A novel chemotherapeutic target for AIDS. J Med Chem 34:2305-2314.
25. Jones TA. 1978. A graphics model building and refinement system for macromolecules. J Appl Crystallogr 11:268-272.
26. Kettner C, Shaw E. 1979 D-Phe-Pro-Arg CH Cl - A selective affinity label for thrombin. Thromb Res 14:969-973.
27. Kettner C, Shaw E. 1981. Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone. Methods Enzymol 80:826-848.
28. Kikumoto R, Tamao Y, Ohkubo K, Tezuka T, Tonomura S, Okamoto S, Funahara Y, Hijikata A. 1980. Thrombin inhibitors. 2. Amide derivatives of N-substituted L-arginine. J Med Chem 23:830-836.
29. Kikumoto R, Tamao Y, Tezuka T, Tonomura S, Hara H, Ninomiya K, Hijikata A, Okamoto S. 1984. Selective inhibition of thrombin by (2R, 4R)-4-methyl-1-(N2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulpho nyl)-L-arginyl)]-2-piperidine-carboxylic acid. Biochemistry 23:85-90.
30. Lattman E. 1985. Use of the rotation and translation function. Methods Enzymol 115.55.
31. Lee AY, Clardy J. 1994. Structure of the trypsin-cyclotheonamide A complex: An all-natural approach. Chem Biol (Introductory issue):10-11.
32. Lee AY, Hagihara M, Karmacharya R, Albers MW, Schreiber SL, Clardy J. 1993. Atomic structure of the trypsin-cyclotheonamide A complex: Lessons for the design of serine protease inhibitors. J Am Chem Soc 115:12619-12620.
33. Lewis SD, Ng AS, Baldwin JJ, Fusetani N, Naylor AM, Shafer JA. 1993. Inhibition of thrombin and other trypsin-like serine proteinases by cyclotheonamide A. Thromb Res 70:173-190.
34. Luzzati V. 1952 Traitement statistique des erreuis dans la determination des structures cristallines. Acta Crystallogr 5:802-810
35. Maryanoff BE, QIU X, Padmanabhan KP, Tulinsky A, Almond HR, Andrade-Goidon P, Greco MN, Kauftman JA, Nicolaou KC, Liu A, Brungs PH, Fusetani N 1993. Molecular basis for the inhibition of human α-thrombin by the macrocyclic peptide cyclotheonamide A. Proc Natl Acad Sci USA 90:8048-8052.
36. Mathews II, Padmanabhan KP, Ganesh V, Tulinsky A, Ishii M, Chen J, Turck CW, Coughlin SR, Fenton JW II 1994. Cristallographic structures of thrombin complexed with thrombin receptor peptides: Existence of expected and novel binding modes. Biochemistry 33:3266-3279.
37. Nesheim ME, Prendergast FG, Mann KG. 1979. Interactions of a fluorescent active-site-directed inhibitor of thrombin: Dansylarginine N-(3-ethyl-1,5-pentanediyl) amide. Biochemistry 18.996-1003
38. Ocain TD, Rich DH. 1992 Keto amide inhibitors of aminopeptidases. J Med Chem 35.451-456.
39. Peet NP, Burkhart JP, Angelastro MR, Giroux EL, Mehdi S, Bey P. Kolb M, Neises B, Schirlin D 1990. Synthesis of peptidyl fluoromethyl ketones and peptidyl α-keto esters as inhibitors of porcine pancreatic elastase, human neutrophil elastase, and rat and human neutrophtl cathepsin G. J Med Chem 33:394-407.
40. Qiu X, Padmanabhan K, Carperos VE, Tulinsky A, Kline T, Maraganore JM, Fenton JW II. 1992. The structure of the hirulog-3-thrombin complex and the nature of the S′ subsites of substrates and inhibitors. Biochemistry 31:11689-11697.
41. Rosen MK, Standaert RF, Galat A, Nakatsuka M, Schreiber SL. 1990. Inhibition of FKBP rotamase activity by immunosuppressant FK506: Twisted amide surrogate. Science 248:863-866.
42. Rossmann MG, Blou DM. 1962. The detection of sub-units within the crystallographic asymmetric unit. Acta Crystallogr 15:24-31.
43. Rydel TJ, Tulinsky A, Bode W, Huber R. 1991. Refined structure of hirudin-thrombin complex. J Mol Biol 221:277-280.
44. Sack JS. 1988. CHAIN - A crystallographic modelling program. J Mol Graph 6:224-225.
45. Silverman RB. 1988. Mechanism-based enzyme mactivation: Chemistry and enzymology. Boca Raton, Florida: CRC Press, pp 5-6.
46. Skrzypezak-Jankun E, Carperos VE, Ravichandran KG, Tulinsky A, West-brook M. Maraganore JM. 1991. The structure of the hirugen and hirulog-1 complexes of α-thrombin. J Mol Biol 221:1379-1393.
47. Stubba MT, Bode W. 1993. A player of many parts: The spotlight falls on thrombin's structure. Thromb Res 69:1-58.
48. Tulinsky A, Qiu X. 1993. Active site and exosite binding of α-thrombin. Blood Coagul Fibrinolysis 4:305-312.
49. Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J, 1991a. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science 252:839-842
50. Van Duyne GD, Standaert RF, Schreiber SL, Clardy J. 1991b. Atomic strueture of the rapamycin human immunophilin FKBP-12 complex. J Am Chem Soc 113:7433-7434.
51. Vijayalalshmi J, Padmanabhan KP, Mann KG, Tulinsky A. 1994 The structure of prethrombin-2: Changes accompanying activation and exosite binding 10 thrombin. Protein Sci 3:2254-2271.
52. Xuong NH, Nielsen C, Hamlin R, Anderson D. 1985. Strategy for data collection from protein crystals using a multiwire counter area detector diffractometer. J Appl Crystallogr 18:342-350.
53. Zdanov A, Wu S, DiMaio J, Konishi Y, Li Y, Wu X, Edwards BFP, Martin PD, Cygler M. 1993. Crystal structure of the complex of human α-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6 Proteins Struct Funct Genet 17:252-265.